Gilead Announces Remdesivir Price Range from $2,340 to $3,120 per Patient
Jun 30, 2020 AM EDT
Gilead Sciences, Inc. announced on Monday that the price of remdesivir, its COVID-19 drug, ranging from $2,340 to $3,120 for each patient in wealthier countries.
